Quadrature Capital »

Crispr Therapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 29k 54.54